发明公开
EP2877162A1 ORAL DOSAGE FORMS FOR MODIFIED RELEASE COMPRISING RUXOLITINIB 审中-公开
口服剂型与鲁索利替尼修饰释放

ORAL DOSAGE FORMS FOR MODIFIED RELEASE COMPRISING RUXOLITINIB
摘要:
The invention essentially relates to oral dosage forms comprising a JAK kinase inhibitor, preferably Ruxolitinib, suitable for modified release, and processes of preparing such oral dosage forms.
信息查询
0/0